Susan M. O’Brien, MD of University of California Irvine discusses Acalabrutinib, ONO-4059 and other novel BTK inhibitors in CLL at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
www.scrippshealth.org/cancer
Susan M. O’Brien, MD of University of California Irvine discusses Acalabrutinib, ONO-4059 and other novel BTK inhibitors in CLL at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
www.scrippshealth.org/cancer